Dar Al Dawa Development and Investment Co. Ltd. Stock Price

ASE:DADI Community·د.أ54.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

DADI Share Price Performance

د.أ1.15

-0.01 (-0.86%)

د.أ1.15

-0.01 (-0.86%)

د.أ1.15

Wed, 24 Jun 26

Share Pricen/a

DADI Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet and good value.

3 Risks

2 Rewards

View Full Analysis

Dar Al Dawa Development and Investment Co. Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.14
: 41.68%
: 8.36%
: 61.8%

View Full Analysis

About DADI

Founded: 1975
Employees: 1111
CEO: Khaled Abedalhameed Harb
WebsiteView website: www.dadgroup.com

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infants. It serves patients and medical communities. Dar Al Dawa Development and Investment Co. Ltd. was incorporated in 1975 and is headquartered in Amman, Jordan.